相关产品推荐更多 >

ARHGEF1 抗体, KO Validated-ARHGEF1 Antibody, KO Validated
¥22
Jun B Proto Oncogene Phospho-Ser79 (JUNB pS79) Antibody/Jun B Proto Oncogene Phospho-Ser79 (JUNB pS79) Antibody/Jun B Proto Oncogene Phospho-Ser79 (JUNB pS79) Antibody
询价
Ran Binding Protein 6 (RANBP6) Antibody/Ran Binding Protein 6 (RANBP6) Antibody/Ran Binding Protein 6 (RANBP6) Antibody
询价
Anti-Human Galectin-8|Anti-Human Galectin-8
询价
Calcium/calmodulin Dependent Protein Kinase II Delta (CAMK2D) Antibody/Calcium/calmodulin Dependent Protein Kinase II Delta (CAMK2D) Antibody/Calcium/calmodulin Dependent Protein Kinase II Delta (CAMK2D) Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Assembly polypeptide 2 (AP2) adaptor polypeptides from bovine brain
- 亚型:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 形态:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 保存条件:
厂家建议常温运输。自购买之日起,保持冻干粉状态于2-4℃,有效期为12个月。抗体溶解之后,建议分装保存于-20℃,请避免反复冻融。
- 克隆性:
单克隆
- 标记物:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 适应物种:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 保质期:
根据订购时间与产品批次判定,欢迎联系艾美捷咨询确认
- 抗原来源:
小鼠
- 目录编号:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 级别:
一抗
- 库存:
小鼠来源毒性抗体:AP-2复合亚基α-adaptin【Ada-1】:IgG
- 供应商:
艾美捷
- 宿主:
小鼠
- 应用范围:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 浓度:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 靶点:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 抗体英文名:
Mouse monoclonal antibody to AP-2 complex subunit alpha-adaptin【Ada-1]: IgG
- 抗体名:
小鼠来源毒性抗体:AP-2复合亚基α-adaptin【Ada-1】:IgG
- 规格:
100ug
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Notes on Making Rat x Y3 Monoclonal Antibody Producing Hybridomas
Although Y3/Ag1.2.3 has its own myeloma light chain, their are numerous characteristics that make this a better parent line for making hybridomas than the 'Y0' chain loss variants or using NS0 to make rat x mouse hybrids. These are: a) Hybridomas
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
secondary antibody review -- data from 99 publications
Signaling 18 IgG Alexa Fluor 488 immunocytochemistry 1:2000 18 IgG Alexa Fluor 568 immunocytochemistry 1:2000 19 donkey IgG HRP western blot 1:3000 detect antibody binding in mouse epithelial cells Amersham Biosciences 19 goat
技术资料暂无技术资料 索取技术资料





